BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25366366)

  • 1. Single agent vinorelbine in pediatric patients with progressive optic pathway glioma.
    Cappellano AM; Petrilli AS; da Silva NS; Silva FA; Paiva PM; Cavalheiro S; Bouffet E
    J Neurooncol; 2015 Jan; 121(2):405-12. PubMed ID: 25366366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood.
    Massimino M; Biassoni V; Miceli R; Schiavello E; Warmuth-Metz M; Modena P; Casanova M; Pecori E; Giangaspero F; Antonelli M; Buttarelli FR; Potepan P; Pollo B; Nunziata R; Spreafico F; Podda M; Anichini A; Clerici CA; Sardi I; De Cecco L; Bode U; Bach F; Gandola L
    J Neurooncol; 2014 Jun; 118(2):305-312. PubMed ID: 24696052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinorelbine in previously treated advanced childhood sarcomas: evidence of activity in rhabdomyosarcoma.
    Casanova M; Ferrari A; Spreafico F; Terenziani M; Massimino M; Luksch R; Cefalo G; Polastri D; Marcon I; Bellani FF
    Cancer; 2002 Jun; 94(12):3263-8. PubMed ID: 12115359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of vinorelbine in patients with androgen-independent prostate cancer.
    Oudard S; Caty A; Humblet Y; Beauduin M; Suc E; Piccart M; Rolland F; Fumoleau P; Bugat R; Houyau P; Monnier A; Sun X; Montcuquet P; Breza J; Novak J; Gil T; Chopin D
    Ann Oncol; 2001 Jun; 12(6):847-52. PubMed ID: 11484963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients > or = 65 years of age: an NCCTG study.
    Baweja M; Suman VJ; Fitch TR; Mailliard JA; Bernath A; Rowland KM; Alberts SR; Kaur JS; Perez EA;
    Ann Oncol; 2006 Apr; 17(4):623-9. PubMed ID: 16520332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboplatin and vinorelbine in untreated locally advanced and metastatic non-small cell lung cancer.
    Horvath L; Boyer M; Clarke S; Beale P; Beith J; Underhill C; Stockler M; Bishop J
    Lung Cancer; 2001 May; 32(2):173-8. PubMed ID: 11325488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancer.
    Havlin KA; Ramirez MJ; Legler CM; Harris LN; Matulonis UA; Hohneker JA; Hayes DF; Winer EP
    Cancer Chemother Pharmacol; 1999; 43(1):68-72. PubMed ID: 9923543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history and outcome of optic pathway gliomas in children.
    Nicolin G; Parkin P; Mabbott D; Hargrave D; Bartels U; Tabori U; Rutka J; Buncic JR; Bouffet E
    Pediatr Blood Cancer; 2009 Dec; 53(7):1231-7. PubMed ID: 19621457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of vinorelbine tartrate in patients with treatment-naive metastatic melanoma.
    Jimeno A; Hitt R; Quintela-Fandino M; Cortés-Funes H
    Anticancer Drugs; 2005 Jan; 16(1):53-7. PubMed ID: 15613904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
    Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
    Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study.
    Lassaletta A; Scheinemann K; Zelcer SM; Hukin J; Wilson BA; Jabado N; Carret AS; Lafay-Cousin L; Larouche V; Hawkins CE; Pond GR; Poskitt K; Keene D; Johnston DL; Eisenstat DD; Krishnatry R; Mistry M; Arnoldo A; Ramaswamy V; Huang A; Bartels U; Tabori U; Bouffet E
    J Clin Oncol; 2016 Oct; 34(29):3537-3543. PubMed ID: 27573663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies: a Children's Oncology Group study.
    Kuttesch JF; Krailo MD; Madden T; Johansen M; Bleyer A;
    Pediatr Blood Cancer; 2009 Oct; 53(4):590-3. PubMed ID: 19533657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive central nervous system involvement in optic pathway gliomas in neurofibromatosis type 1.
    Shaikh F; Johnston D; Michaud J; Hurteau J; Vassilyadi M; Keene D
    Pediatr Blood Cancer; 2011 Oct; 57(4):688-6690. PubMed ID: 21465640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vinorelbine in androgen-independent metastatic prostatic carcinoma--a phase II study.
    Morant R; Hsu Schmitz SF; Bernhard J; Thürlimann B; Borner M; Wernli M; Egli F; Forrer P; Streit A; Jacky E; Hanselmann S; Bauer J; Hering F; Schmid HP
    Eur J Cancer; 2002 Aug; 38(12):1626-32. PubMed ID: 12142053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of single-agent oral vinorelbine in patients with pretreated advanced non-small-cell lung cancer.
    Rossi D; Catalano V; Alessandroni P; Fedeli A; Fedeli SL; Giordani P; Baldelli AM; Casadei V; Ceccolini M; Ugolini M; Dennetta D; Catalano G
    Clin Lung Cancer; 2007 May; 8(6):382-5. PubMed ID: 17562239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of relapsing glioblastoma multiforme responding to vinorelbine.
    Biassoni V; Casanova M; Spreafico F; Gandola L; Massimino M
    J Neurooncol; 2006 Nov; 80(2):195-201. PubMed ID: 16670944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of weekly i.v. vinorelbine as a single agent in first-line advanced breast cancer chemotherapy. The Latin-American experience.
    Bruno S; Puerto VL; Mickiewicz E; Hegg R; Texeira LC; Gaitan L; Martinez L; Fernandez O; Otero J; Kesselring G
    Am J Clin Oncol; 1995 Oct; 18(5):392-6. PubMed ID: 7572754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel-cisplatin versus vinorelbine-cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study.
    Douillard JY; Gervais R; Dabouis G; Le Groumellec A; D'Arlhac M; Spaeth D; Coudert B; Caillaud D; Monnier A; Clary C; Maury B; Mornet M; Rivière A; Clouet P; Couteau C
    Ann Oncol; 2005 Jan; 16(1):81-9. PubMed ID: 15598943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer.
    Crawford J; O'Rourke M; Schiller JH; Spiridonidis CH; Yanovich S; Ozer H; Langleben A; Hutchins L; Koletsky A; Clamon G; Burman S; White R; Hohneker J
    J Clin Oncol; 1996 Oct; 14(10):2774-84. PubMed ID: 8874339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and Outcome in 65 Children with Optic Pathway Gliomas.
    El Beltagy MA; Reda M; Enayet A; Zaghloul MS; Awad M; Zekri W; Taha H; El-Khateeb N
    World Neurosurg; 2016 May; 89():525-34. PubMed ID: 26898488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.